Product
AB598
1 clinical trial
12 indications
Indication
Advanced CancerIndication
Advanced MalignanciesIndication
Bladder CancerIndication
Cervical CancerIndication
Esophageal cancerIndication
Stomach CancerIndication
Gastroesophageal-junction CancerIndication
Head and Neck Squamous Cell CarcinomaIndication
non-small cell lung cancerIndication
Ovarian CancerIndication
Renal Cell CarcinomaIndication
Triple Negative Breast CancerClinical trial
A Phase 1/1b Study to Evaluate the Safety and Tolerability of AB598 Monotherapy and Combination Therapy in Participants With Advanced MalignanciesStatus: Recruiting, Estimated PCD: 2025-08-01